The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
The DNA sequence of human chromosome 21
Hattori, M., Fujiyama, A., Taylor, T. D., Watanabe, H., Yada, T., Park, H.-S., Toyoda, A., Ishii, K., Totoki, Y., Choi, D.-K., et al. (2000) · Nature · doi:10.1038/35012518 · Cited by 1,474
Risks of leukaemia and solid tumours in individuals with Down's syndrome
Hasle, H., Clemmensen, I. H., & Mikkelsen, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05264-2 · Cited by 892
Sorlie, P. D., Backlund, E., & Keller, J. B. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.7.949 · Cited by 833
Accuracy of Death Certificates for Coding Coronary Heart Disease as the Cause of Death
Lloyd-Jones, D. M., Martin, D. O., Larson, M. G., & Levy, D. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-12-199812150-00005 · Cited by 480
AN ALTERNATIVE TO THE PROPORTIONATE MORTALITY RATIO
MIETTINEN, O. S., & WANG, J.-D. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113161 · Cited by 233
ANALYTICAL POTENTIAL FOR MULTIPLE CAUSE-OF-DEATH DATA
ISRAEL, R. A., ROSENBERG, H. M., & CURTIN, L. R. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114375 · Cited by 191
A tumor profile in Down syndrome
Satgé, D., Sommelet, D., Geneix, A., Nishi, M., Malet, P., & Vekemans, M. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980707)78:3<207::aid-ajmg1>3.3.co;2-q · Cited by 182
Mortality in Down’s syndrome in relation to congenital malformations
Frid, C., Drott, P., Lundell, B., Rasmussen, F., & Annerén, G. (1999) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1999.00198.x · Cited by 161
Gittelsohn, A. M., & Senning, J. H. (1979) · American Journal of Public Health · doi:10.2105/ajph.69.7.680 · Cited by 145
Cited by
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Roizen, N. J., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,331
Folkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209
Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0143-7 · Cited by 964
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis
Holland, A. J., & Cleveland, D. W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2718 · Cited by 859
Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome
Stochholm, K., Juul, S., Juel, K., Naeraa, R. W., & Højbjerg Gravholt, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0558 · Cited by 652
Sherman, S. L., Allen, E. G., Bean, L. H., & Freeman, S. B. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20157 · Cited by 529
The changing survival profile of people with Down's syndrome: implications for genetic counselling
Glasson, E., Sullivan, S., Hussain, R., Petterson, B., Montgomery, P., & Bittles, A. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620506.x · Cited by 475
Infections and immunodeficiency in Down syndrome
Ram, G., & Chinen, J. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04335.x · Cited by 465
Current Estimate of Down Syndrome Population Prevalence in the United States
Presson, A. P., Partyka, G., Jensen, K. M., Devine, O. J., Rasmussen, S. A., McCabe, L. L., & McCabe, E. R. B. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.06.013 · Cited by 416
Self-citationClinical practice: The care of children with Down syndrome
Weijerman, M. E., & de Winter, J. P. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1253-0 · Cited by 382
People with intellectual disability: What do we know about adulthood and life expectancy?
Coppus, A. M. W. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1123 · Cited by 374
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
Baek, K.-H., Zaslavsky, A., Lynch, R. C., Britt, C., Okada, Y., Siarey, R. J., Lensch, M. W., Park, I.-H., Yoon, S. S., Minami, T., et al. (2009) · Nature · doi:10.1038/nature08062 · Cited by 373
Framing the Public Health of Caregiving
Talley, R. C., & Crews, J. E. (2007) · American Journal of Public Health · doi:10.2105/ajph.2004.059337 · Cited by 372
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Ma, J., & Waxman, D. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0715 · Cited by 370
Bertapelli, F., Pitetti, K., Agiovlasitis, S., & Guerra-Junior, G. (2016) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2016.06.018 · Cited by 352
Gene Copy-Number Alterations: A Cost-Benefit Analysis
Tang, Y.-C., & Amon, A. (2013) · Cell · doi:10.1016/j.cell.2012.11.043 · Cited by 348
Phenotype associated with APP duplication in five families
Cabrejo, L., Guyant-Marechal, L., Laquerriere, A., Vercelletto, M., De La Fourniere, F., Thomas-Anterion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., et al. (2006) · Brain · doi:10.1093/brain/awl237 · Cited by 343
Defining ‘chromosomal instability’
Geigl, J. B., Obenauf, A. C., Schwarzbraun, T., & Speicher, M. R. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.006 · Cited by 341
Estimation of the number of people with Down syndrome in the United States
de Graaf, G., Buckley, F., & Skotko, B. G. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.127 · Cited by 340
Endogenous angiogenesis inhibitors
FOLKMAN, J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321
Understanding Health Disparities and Inequities Faced by Individuals with Intellectual Disabilities
Ouellette‐Kuntz, H. (2005) · Journal of Applied Research in Intellectual Disabilities · doi:10.1111/j.1468-3148.2005.00240.x · Cited by 297
Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995–2011)
Natoli, J. L., Ackerman, D. L., McDermott, S., & Edwards, J. G. (2012) · Prenatal Diagnosis · doi:10.1002/pd.2910 · Cited by 293
Holland, A. J., & Cleveland, D. W. (2012) · EMBO reports · doi:10.1038/embor.2012.55 · Cited by 288
Congenital Heart Surgery Outcomes in Down Syndrome: Analysis of a National Clinical Database
Fudge, J. C., Li, S., Jaggers, J., O'Brien, S. M., Peterson, E. D., Jacobs, J. P., Welke, K. F., Jacobs, M. L., Li, J. S., & Pasquali, S. K. (2010) · Pediatrics · doi:10.1542/peds.2009-3245 · Cited by 282
Molecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278
Alzheimer's disease in Down syndrome: Neurobiology and risk
Zigman, W. B., & Lott, I. T. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20163 · Cited by 278
Hosking, F. J., Carey, I. M., Shah, S. M., Harris, T., DeWilde, S., Beighton, C., & Cook, D. G. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303240 · Cited by 265
Atypical aging in down syndrome
Zigman, W. B. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1128 · Cited by 260
Prevalence of Down Syndrome Among Children and Adolescents in 10 Regions of the United States
Shin, M., Besser, L. M., Kucik, J. E., Lu, C., Siffel, C., Correa, A., & Collaborative, T. C. A. M. P. A. S. (. (2009) · Pediatrics · doi:10.1542/peds.2009-0745 · Cited by 258
Sudden Death and Use of Stimulant Medications in Youths
Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., Greenhill, L., & Cooper, T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040472 · Cited by 253
Intrinsic defect of the immune system in children with Down syndrome: a review
Kusters, M. A. A., Verstegen, R. H. J., Gemen, E. F. A., & De Vries, E. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03890.x · Cited by 252
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
“Not only is trisomy 21 the most frequent cause of mental retardation [2,3], due to the extensive number of chromosome 21 genes [4], there is an extremely high incidence of congenital anomalies such as important cardiac and gastrointestinal malformations in trisomy 21 [5].”
BackgroundTrisomy 21 and early brain development
Haydar, T. F., & Reeves, R. H. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.001 · Cited by 200
“These include cardiac malformations [2], gastrointestinal anomalies [3], craniofacial and skeletal anomalies [4, 5], and contrasting cancer phenotypes which include an increased frequency of childhood leukemia and reduced prevalence of many types of cancer in adults [6, 7].”
BackgroundAssociation of Alzheimer Disease With Life Expectancy in People With Down Syndrome
Iulita, M. F., Garzón Chavez, D., Klitgaard Christensen, M., Valle Tamayo, N., Plana-Ripoll, O., Rasmussen, S. A., Roqué Figuls, M., Alcolea, D., Videla, L., Barroeta, I., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.12910 · Cited by 195
Self-citationEndogenous inhibitors of angiogenesis
Ribatti, D. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.019 · Cited by 191
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
Hithersay, R., Startin, C. M., Hamburg, S., Mok, K. Y., Hardy, J., Fisher, E. M. C., Tybulewicz, V. L. J., Nizetic, D., & Strydom, A. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.3616 · Cited by 176
The prevalence and determinants of obesity in adults with intellectual disabilities
Melville, C. A., Hamilton, S., Hankey, C. R., Miller, S., & Boyle, S. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00296.x · Cited by 170
Outcome Measures for Clinical Trials in Down Syndrome
Esbensen, A. J., Hooper, S. R., Fidler, D., Hartley, S. L., Edgin, J., d'Ardhuy, X. L., Capone, G., Conners, F. A., Mervis, C. B., Abbeduto, L., et al. (2017) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-122.3.247 · Cited by 153
Chen, J.-Y., Lin, J.-R., Tsai, F.-C., & Meyer, T. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.009 · Cited by 144
Usp16 contributes to somatic stem-cell defects in Down’s syndrome
Adorno, M., Sikandar, S., Mitra, S. S., Kuo, A., Nicolis di Robilant, B., Haro-Acosta, V., Ouadah, Y., Quarta, M., Rodriguez, J., Qian, D., et al. (2013) · Nature · doi:10.1038/nature12530 · Cited by 134
Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
Karlsen, A. S., & Pakkenberg, B. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr033 · Cited by 75
Ponroy Bally, B., Farmer, W. T., Jones, E. V., Jessa, S., Kacerovsky, J. B., Mayran, A., Peng, H., Lefebvre, J. L., Drouin, J., Hayer, A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa003 · Cited by 49
Synaptic Pathology of Down Syndrome
Garner, C. C., & Wetmore, D. Z. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_20 · Cited by 33
Meulepas, J. M., Ronckers, C. M., Merks, J., Weijerman, M. E., Lubin, J. H., & Hauptmann, M. (2016) · Journal of Radiological Protection · doi:10.1088/0952-4746/36/4/953 · Cited by 29
Metadata
- Authors
- Yang, Q., Rasmussen, S. A., & Friedman, J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 359
- Issue
- 9311
- Pages
- 1019-1025
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2025782007
- Cited by
- 847
- References
- 19
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.